Status:
COMPLETED
The Contribution of Incretin Hormones to Post-prandial Glucose Metabolism After Roux-en-Y Gastric Bypass
Lead Sponsor:
Adrian Vella
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Center for Research Resources (NCRR)
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
20-70 years
Phase:
EARLY_PHASE1
Brief Summary
The study is being undertaken to understand how the Roux-en-Y Gastric Bypass procedure can affect insulin secretion after meals. The hypothesis of this study is the Disposition Index is decreased in s...
Eligibility Criteria
Inclusion
- Inclusion Criteria Roux-en-Y Gastric Bypass (RYGB)Subjects:
- Subjects who have undergone RYGB
- Inclusion Criteria Healthy Subjects:
- Must match RYGB subjects in age, weight, and gender
- Subjects will be without active systemic illness
- Exclusion Criteria all Subjects:
- Subjects \<20 years old and \>70 years old
- For Female Subjects: positive pregnancy text at the time of enrollment or study
- Subjects with functional or organic bowel symptoms.
Exclusion
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01843881
Start Date
March 1 2012
End Date
December 1 2013
Last Update
December 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905